Shareholding for the Period Ended June 30, 2018
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here12-07-2018
12-07-2018
US drugmaker Pfizer says it will split business into three units Now
The three new units are innovative medicines, established medicines and consumer healthcare11-07-2018
Trump slams drug companies for raising prices
US President Donald Trump today slammed Pfizer and other pharma companies for raising prices of drugs and said that they should be ashamed of it. Pf10-07-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Listing Regulations, please find attached the details of the meeting scheduled with an Analyst/Institutional Investor: Please note that the attached schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. The attached schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.20-06-2018
Pfizer to pay $23.85 million to resolve US kickbacks case
The accord resolves allegations that Pfizer violated the federal False Claims Act, the Justice Department said.24-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the financial results for the quarter and financial year ended March 31, 2018. Please take the above on record.07-05-2018
Board recommends Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2018, inter alia, has recommended a dividend of 200% (Rs. 20 per equity share of Rs. 10 each) for the financial year ended March 31, 2018. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on September 11, 2018.07-05-2018
Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2018.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith audited financial results for the financial year ended March 31, 2018, Statement of Assets and Liabilities as on March 31, 2018, Declaration with respect to Audit Report with unmodified opinion and the Auditor's Report by Auditors, M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of...07-05-2018
Pfizer hits an over two-year high ahead of March quarter results
The stock was up 5% to Rs 2,434 on the BSE in intra-day trade, trading at its highest level since January 4, 2016.07-05-2018